FGF21 and Insulin resistance: Similarly, the plasma FGF21 concentration was positively associated with homeostatic model assessment of insulin resistance (HOMA-IR) in patients receiving lifestyle hypoglycemic therapy only, and patients with higher baseline plasma FGF21 concentrations also had a relatively high risk of glucose progression over a 5-year period (76).